ROSEN, LEADING INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK
10 mars 2025 18h23 HE
|
The Rosen Law Firm PA
NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Merck & Co., Inc. (NYSE: MRK) between February 3,...
ROSEN, A LEADING NATIONAL FIRM, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK
04 mars 2025 19h57 HE
|
The Rosen Law Firm PA
NEW YORK, March 04, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Merck & Co., Inc. (NYSE: MRK) between February 3,...
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK
26 févr. 2025 19h00 HE
|
The Rosen Law Firm PA
NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Merck & Co., Inc. (NYSE: MRK) between February 3, 2022...
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK
20 févr. 2025 16h50 HE
|
The Rosen Law Firm PA
NEW YORK, Feb. 20, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Merck & Co., Inc. (NYSE: MRK) between February 3, 2022...
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK
14 févr. 2025 15h43 HE
|
The Rosen Law Firm PA
NEW YORK, Feb. 14, 2025 (GLOBE NEWSWIRE) -- WHY: New York, N.Y., February 14, 2025. Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of...
Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study
29 mai 2024 02h00 HE
|
Anaveon
Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study
Vaccine Contract Manufacturing Market To Reach USD 10.8 Billion By 2032 Report By DataHorizzon Research
22 janv. 2024 07h00 HE
|
DataHorizzon Research
Fort Collins, Colorado, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The Vaccine Contract Manufacturing Market size was valued at USD 3.7 Billion in 2022 and is anticipated to reach USD 10.8 Billion by 2032 at...
The Advancing Health Online (AHO) Initiative Invests $5M through the Vaccine Confidence Fund for Research to Understand How to Boost Vaccination Confidence through Social Media
27 juin 2023 15h00 HE
|
Global Impact
ALEXANDRIA, VA, June 27, 2023 (GLOBE NEWSWIRE) -- Global Impact, as fiscal sponsor for the Advancing Health Online (AHO) Initiative, is pleased to announce the selection of 11 organizations that...
Global Impact launches new $5M research fund - Vaccine Confidence Fund II to further understand how Social Media may be leveraged to Increase Vaccination Confidence and Uptake
05 août 2022 18h19 HE
|
Global Impact
Alexandria, VA, Aug. 05, 2022 (GLOBE NEWSWIRE) -- Global Impact, on behalf of the Alliance for Advancing Health Online (AAHO), is pleased to announce the launch of an additional round of Request for...
Global Impact, on Behalf of the Alliance for Advancing Health Online (AAHO), Shares Research and Announces Upcoming New Program at 75th World Health Assembly
25 mai 2022 11h30 HE
|
Global Impact
Alexandria, VA, May 25, 2022 (GLOBE NEWSWIRE) -- Today, a preliminary insights report from research supported through the Vaccine Confidence Fund was released at the 75th World Health Assembly. The...